Patorno, E <br/><br/>
Comparative cardiovascular safety of glucagon-like peptide-1 receptor agonists versus other antidiabetic drugs in routine care: a cohort study.  [electronic resource] 

 -  Diabetes, obesity & metabolism  08 2016 
 - 755-65 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1463-1326 
<br/><br/><label>Standard No.: </label>10.1111/dom.12665  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Angina, Unstable--epidemiology<br/>Cardiovascular Diseases--epidemiology<br/>Cohort Studies<br/>Databases, Factual<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Dipeptidyl-Peptidase IV Inhibitors--therapeutic use<br/>Drug Therapy, Combination<br/>Female<br/>Glycated Hemoglobin--metabolism<br/>Hospitalization--statistics & numerical data<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Incretins--therapeutic use<br/>Insulin--therapeutic use<br/>Male<br/>Metformin--therapeutic use<br/>Middle Aged<br/>Myocardial Infarction--epidemiology<br/>Myocardial Revascularization--statistics & numerical data<br/>Propensity Score<br/>Proportional Hazards Models<br/>Retrospective Studies<br/>Stroke--epidemiology<br/>Sulfonylurea Compounds--therapeutic use<br/>Glucagon-Like Peptide-1 Receptor Agonists